Rolf Grosser

USPTO Granted Patents = 44 (Patent Applications = 2)

CIPO Patents = 6

EPO Patents = 8 (Patent Applications = 2)

Average Co-Inventor Count = 6.7

ph-index = 9

Forward Citations = 232(Granted Patents)

Location History:

Bayerwerk, DE (1995 - 1996)
Leverkusen, DE (1988 - 2023)

Company Filing History:

25 out of 12,157

Bayer Aktiengesellschaft

patents

5 out of 721

Bayer Intellectual Property Gmbh

patents

4 out of 192

Bayer Schering Pharma Ag

patents

4. 3 out of 53

Aicuris Gmbh + Co. Kg.

patents

5. 2 out of 76

Bayer Healthcare Aktiengesellschaft

patents

6. 1 out of 9

Aicuris Anti-infective Cures Gmbh

Bayer Pharma Aktiengesellschaft

Lanxess Deutschland Gmbh

patents

Years Active: 1988-2023

Loading Chart...

44 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. RE49698 - Substituted dihydroquinazolines (2023-10-17),

2. RE46791 - Substituted dihydroquinazolines (2018-04-16),

3. 9051316 - Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use (2015-06-09),

4. 8513255 - Substituted dihydroquinazolines (2013-08-20),

5. 8436180 - Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof (2013-05-07),

6. 8404723 - 3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases (2013-03-26),

7. 8404709 - Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof (2013-03-26),

8. 8399471 - Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same (2013-03-19),

9. 8343981 - Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents (2013-01-01),

10. 8314113 - Substituted dihydroquinazolines II (2012-11-20),

11. 8188129 - (−)-enantiomer of the 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (2012-05-29),

12. 8063234 - Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof (2011-11-22),

13. 8058447 - 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof (2011-11-15),

14. 7989633 - 4-Chromenonyl-1,4-dihydropyridines and their use (2011-08-02),

15. 7960387 - 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses (2011-06-14),

Title: The Innovative Contributions of Rolf Grosser

Introduction

Rolf Grosser, a notable inventor based in Leverkusen, Germany, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 44 patents, his work focuses particularly on the development of antiviral agents, which are crucial in the fight against various diseases.

Latest Patents

Among Grosser's latest inventions are his patented substitutes for dihydroquinazolines. These innovations explore processes for the preparation of these compounds, highlighting their potential use in creating medicaments for the treatment and prophylaxis of diseases. Notably, they serve as antiviral agents, offering particular efficacy against cytomegaloviruses.

Career Highlights

Throughout his career, Grosser has been associated with prominent organizations, including Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His tenure at these companies has been marked by groundbreaking research and development that led to tangible advancements in pharmaceutical applications.

Collaborations

Grosser’s work has been enriched by collaborations with distinguished colleagues such as Walter Lange and Dieter Arlt. Together, they have contributed to pivotal research that has furthered the understanding and application of medicinal compounds in treating viral infections.

Conclusion

Rolf Grosser's dedication to the field of medicinal chemistry and his innovative approach to developing antiviral agents underscore his importance as an inventor. His extensive experience and numerous patents demonstrate his significant role in advancing healthcare solutions, emphasizing the impact of academic and industrial collaboration in innovation.

This text is generated by artificial intelligence and may not be accurate.